Yuyu Pharma, Inc. (KOSE:A000220) announced a private placement of 30th domestic bearer type non-guaranteed private convertible bonds for gross proceeds of KRW 30,000,000,000 on June 11, 2021. The bonds will be issued at par. The transaction will include participation from Eugene Investment & Securities Co.,Ltd. (KOSE:A001200)for KRW 4,000,000,000; KB Securities Co., Ltd. for KRW 9,900,000,000; NH Investment & Securities Co., Ltd. (KOSE:A005940)for KRW 3,000,000,000; Mirae Asset Securities Co., Ltd. (KOSE:A006800) for KRW 3,600,000,000; Shinhan Financial Investment Co., Ltd. for KRW 2,000,000,000; Samsung Securities Co., Ltd. (KOSE:A016360) for KRW 2,500,000,000; DB Financial Investment Co., Ltd. (KOSE:A016610) for KRW 1,000,000,000; Korea Investment & Securities Co., Ltd. for KRW 1,000,000,000; and Industrial Bank of Korea (KOSE:A024110) for KRW 3,000,000,000.

The bonds are zero-coupon and will mature on June 15, 2026. The bonds are fully convertible into 3,205,128 common shares of the company representing 11.83% stake at a fixed conversion price of KRW 9,360 per share. The conversion period of the bonds will be from June 15, 2022 to June 15, 2026.

The subscription and payment date is June 15, 2021. The transaction was approved by the board of directors of the company. The bonds will be subject to a one year hold period.